investor-state disputes | ISDS

Investor-state dispute settlement (ISDS) refers to a way of handling conflicts under international investment agreements whereby companies from one party are allowed to sue the government of another party. This means they can file a complaint and seek compensation for damages. Many BITs and investment chapters of FTAs allow for this if the investor’s expectation of a profit has been negatively affected by some action that the host government took, such as changing a policy. The dispute is normally handled not in a public court but through a private abritration panel. The usual venues where these proceedings take place are the International Centre for Settlement of Investment Disputes (World Bank), the International Chamber of Commerce, the United Nations Commission on International Trade Law or the International Court of Justice.

ISDS is a hot topic right now because it is being challenged very strongly by concerned citizens in the context of the EU-US TTIP negotiations, the TransPacific Partnership talks and the CETA deal between Canada and the EU.

Kluwer Arbitration Blog | 7-Mar-2017
Two recently finalized cases against Latin America states provide several noteworthy points for further debates on the host states’ counterclaims towards investors.
DNA | 6-Mar-2017
Sitharaman clarified that the negotiation should not get lost in peripheral issues and should focus on bringing in promotion and protection elements.
S2B | 6-Mar-2017
Position du réseau S2B sur la proposition de la Commission d’un mécanisme multilatéral de règlement des différends investisseurs-Etats (RDIE ou ISDS en anglais).
Globes | 4-Mar-2017
The international arbitration panel ruled that Egypt failed to protect the Sinai pipeline from terrorists.
Open Canada | 3-Mar-2017
NAFTA has its fair share of critics who want to see it updated. But if Trump has his way, a re-negotiated agreement may prove disappointing.
MSF | 3-Mar-2017
Médecins Sans Frontières (MSF) raises concerns over provisions under negotiation in the RCEP investment chapter that threaten to restrict access to affordable medicines for millions of people
Financial Express | 2-Mar-2017
Fresh investments by European companies in India and vice versa after April 1 won’t enjoy legal protection under any bilateral arrangement, as India has decided not to accede to requests by the European Union.
People’s Coalition on Food Sovereignty | 2-Mar-2017
RCEP will be harmful to developing countries’ struggle for industrialization, access to cheaper medicines, quality social services, and protection of the environment